Corrigendum: Targeted proteomics-determined multi-biomarker profiles developed classifier for prognosis and immunotherapy responses of advanced cervical cancer

• Jin Li,
• Jin Li,
• Xu Zhang,
• Xu Zhang,
• Liuke Yang,
• Youwei Zhu,
• Rongrong Gao,
• Tiancheng Zhang,
• Tiancheng Zhang,
• Xuwen Chen,
• Jun Fu,
• Gaoyang He,
• Huijuan Shi,
• Huijuan Shi,
• Shenjie Peng,
• XiaoHua Wu,
• XiaoHua Wu

Affiliations

Jin Li

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China

Jin Li

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China

Xu Zhang

NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Xu Zhang

Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Liuke Yang

College of plant protection, Nanjing Agricultural University, Nanjing, China

Youwei Zhu

Clinical Center of Bio-Therapy at Zhongshan Hospital & Institutes of Biomedical Sciences, Shanghai Public Health Clinical Center, Fudan University, Shanghai, China

Rongrong Gao

Clinical Center for Biotherapy at Zhongshan Hospital, Fudan University, Shanghai, China

Tiancheng Zhang

NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Tiancheng Zhang

Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Xuwen Chen

Shanghai Kelin Clinical Bioinformatics Institute, Shanghai, China

Jun Fu

LC-Bio Technology Co., Ltd, Hangzhou, China

Gaoyang He

LC-Bio Technology Co., Ltd, Hangzhou, China

Huijuan Shi

NHC Key Lab of Reproduction Regulation, Shanghai Engineering Research Center of Reproductive Health Drug and Devices, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Huijuan Shi

Shanghai-MOST Key Laboratory of Health and Disease Genomics, NHC Key Lab of Reproduction Regulation, Shanghai Institute for Biomedical and Pharmaceutical Technologies, Shanghai, China

Shenjie Peng

0Fudan University, Shanghai, China

XiaoHua Wu

Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Fudan University, Shanghai, China

XiaoHua Wu

Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China